期刊文献+

瑞戈非尼致直肠癌患者高血压1例 被引量:2

下载PDF
导出
摘要 1病例资料患者,男,66岁,2019年10月18日因“直肠癌术后4年余,肺转移2年余”入院。既往无高血压病史。入院体检:T 36.7℃,P 70次/min,R 16次/min,BP 130/84 mmHg,身高170 cm,体质量70 kg,体质指数(BMI)24.22 kg·m^-2,体表面积1.80 m2,卡氏功能状态评分(KPS)80分,疼痛数字评分(NRS)3分,予曲马多缓释片100 mg q12h止痛,神志清,精神可。
出处 《中国药师》 CAS 2020年第6期1152-1153,共2页 China Pharmacist
  • 相关文献

参考文献2

二级参考文献87

  • 1Luis A. Diaz,Richard T. Williams,Jian Wu.The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers. Nature . 2012
  • 2Jim Cassidy,Stephen Clarke,Eduardo Díaz-Rubio,Werner Scheithauer,Arie Figer,Ralph Wong,Sheryl Koski,Mikhail Lichinitser,Tsai-Shen Yang,Fern,o Rivera,Felix Couture,Florin Sirzén,Leonard Sal.Randomized Phase III Study of Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid Plus Oxaliplatin As First-Line Therapy for Metastatic Colorectal Cancer. Japanese Journal of Clinical Oncology . 2008
  • 3Van Cutsem Eric,K?hne Claus-Henning,Hitre Erika,Zaluski Jerzy,Chang Chien Chung-Rong,Makhson Anatoly,D’Haens Geert,Pintér Tamás,Lim Robert,Bodoky Gy?rgy,Roh Jae Kyung,Folprecht Gunnar,Ruff Paul,Stroh Christopher,Tejpar Sabine,Schlichting.Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer. The New England Quarterly . 2009
  • 4Bokemeyer Carsten,Bondarenko Igor,Makhson Anatoly,Hartmann Joerg T,Aparicio Jorge,de Braud Filippo,Donea Serban,Ludwig Heinz,Schuch Gunter,Stroh Christopher,Loos Anja H,Zubel Angela,Koralewski Piotr.Fluorouracil, leucovorin, and oxaliplatin with and without cetuximab in the first-line treatment of metastatic colorectal cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology . 2008
  • 5Van Cutsem E,Peeters M,Siena S,et al.Open-label phase III trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy-refractory metastatic colorectal cancer. Journal of Clinical Oncology . 2007
  • 6Jonker Derek J,O’Callaghan Chris J,Karapetis Christos S,Zalcberg John R,Tu Dongsheng,Au Heather-Jane,Berry Scott R,Krahn Marianne,Price Timothy,Simes R John,Tebbutt Niall C,van Hazel Guy,Wierzbicki Rafal,Langer Christiane,Moore Malcolm J.Cetuximab for the treatment of colorectal cancer. The New England Quarterly . 2007
  • 7Scott M. Wilhelm,Jacques Dumas,Lila Adnane.Regorafenib (BAY 73-4506): a new oral multikinase inhibitor of angiogenic, stromal and oncogenic receptor tyrosine kinases with potent preclinical antitumor activity. International Journal of Cancer . 2011
  • 8Amado Rafael G,Wolf Michael,Peeters Marc,Van Cutsem Eric,Siena Salvatore,Freeman Daniel J,Juan Todd,Sikorski Robert,Suggs Sid,Radinsky Robert,Patterson Scott D,Chang David D.Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology . 2008
  • 9Karapetis Christos S,Khambata-Ford Shirin,Jonker Derek J,O’Callaghan Chris J,Tu Dongsheng,Tebbutt Niall C,Simes R John,Chalchal Haji,Shapiro Jeremy D,Robitaille Sonia,Price Timothy J,Shepherd Lois,Au Heather-Jane,Langer Christiane,Moore Malc.K-ras mutations and benefit from cetuximab in advanced colorectal cancer. The New England Quarterly . 2008
  • 10Ferrara N,Henzel W J.Pituitary follicular cells secret a novel heparin-binding growth factor specific for vascular endothelial cells. Biochemical and Biophysical Research Communications . 1989

共引文献20

同被引文献15

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部